VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NOCNorthrop Grumman Corporation
$500.03$71.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksNOCFinancials

Northrop Grumman Corporation (NOC) Financials

30Y historyFree accessUpdated daily

Revenue growth has stabilized at 4.4% year-over-year as of 2026Q1, though operating margins remain constrained near 10% due to the high fixed-cost base inherent in specialized defense manufacturing.

NOC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue42.37B41.95B41.03B39.29B36.6B35.67B36.8B33.84B30.09B25.8B24.51B23.53B23.98B24.66B25.22B26.41B28.14B33.76B33.89B32.02B30.15B30.72B29.85B26.21B17.21B13.56B7.62B8.99B8.9B9.15B8.07B
Revenue Growth %4.95%2.24%4.44%7.34%2.62%-3.08%8.74%12.45%16.63%5.28%4.17%-1.89%-2.77%-2.21%-4.52%-6.15%-16.63%-0.39%5.84%6.2%-1.87%2.91%13.92%52.31%26.91%77.97%-15.31%1.04%-2.74%13.41%18.38%
Cost of Goods Sold33.67B33.64B32.67B32.74B29.13B28.4B29.32B26.58B23.3B19.85B18.73B17.88B18.38B19.28B19.64B20.79B22.85B28.13B27.7B25.8B24.66B25.59B25.14B22.32B14.1B11.22B5.07B6.46B6.54B6.62B5.85B
COGS % of Revenue-80.19%79.62%83.33%79.58%79.62%79.68%78.55%77.43%76.93%76.43%76.02%76.64%78.19%77.87%78.7%81.19%83.34%81.74%80.59%81.8%83.3%84.2%85.18%81.97%82.75%66.49%71.85%73.43%72.35%72.47%
Gross Profit8.69B8.31B8.36B6.55B7.47B7.27B7.48B7.26B6.79B5.95B5.78B5.64B5.6B5.38B5.58B5.63B5.29B5.63B6.19B6.21B5.49B5.13B4.72B3.88B3.1B2.34B2.55B2.53B2.37B2.53B2.22B
Gross Margin %20.52%19.81%20.38%16.67%20.42%20.38%20.32%21.45%22.57%23.07%23.57%23.98%23.36%21.81%22.13%21.3%18.81%16.66%18.26%19.41%18.2%16.7%15.8%14.82%18.03%17.25%33.51%28.15%26.57%27.65%27.53%
Gross Profit Growth %--0.59%27.64%-12.35%2.83%-2.81%3.02%6.89%14.06%3.06%2.39%0.73%4.13%-3.6%-0.82%6.27%-5.88%-9.11%-0.4%13.23%6.96%8.75%21.47%25.21%32.62%-8.38%0.83%7.06%-6.56%13.91%24.9%
Operating Expenses4B4.03B3.99B4.01B3.87B1.62B3.41B3.29B3.04B2.71B2.63B2.57B2.4B2.26B2.4B23.14B2.47B3.14B6.3B3.21B3.03B2.95B2.68B2.35B1.71B1.33B1.46B1.56B1.61B1.65B1.56B
OpEx % of Revenue-9.61%9.73%10.22%10.58%4.53%9.27%9.72%10.1%10.51%10.74%10.91%10.03%9.15%9.53%87.6%8.77%9.31%18.59%10.02%10.06%9.61%8.97%8.95%9.94%9.85%19.1%17.38%18.07%18.04%19.38%
Selling, General & Admin4B4.03B2.89B3.91B1.14B227M3.25B4.29B2.62B1.48B2.97B2.57B2.4B2.26B2.45B2.35B2.47B3.14B3.24B3.21B3.03B2.95B2.71B2.35B1.71B1.33B1.07B1.17B1.22B1.23B1.2B
SG&A % of Revenue-9.61%7.05%9.94%3.1%0.64%8.83%12.68%8.7%5.72%12.12%10.91%10.03%9.15%9.72%8.9%8.77%9.31%9.56%10.02%10.06%9.61%9.08%8.95%9.94%9.85%14.1%13.05%13.66%13.47%14.83%
Research & Development01.1B1.1B1.2B1.2B1.1B0953M764M639M705M712M569M507M520M0000000000000000
R&D % of Revenue-2.62%2.68%3.05%3.28%3.08%-2.82%2.54%2.48%2.88%3.03%2.37%2.06%2.06%----------------
Other Operating Expenses0-1.1B-1M-1.09B1.54B290M164M-1.95B-341M596M-1.04B-712M-569M-507M00003.06B000-35M000381M389M393M418M367M
Operating Income4.7B4.28B4.37B2.54B3.6B5.65B4.07B3.97B3.78B3.3B3.19B3.08B3.2B3.12B3.13B3.28B2.83B2.48B-111M3.01B2.45B2.18B2.04B1.54B1.39B1B1.1B969M756M880M658M
Operating Margin %11.08%10.2%10.65%6.46%9.84%15.84%11.05%11.73%12.56%12.79%13.03%13.07%13.33%12.66%12.41%12.4%10.05%7.36%-0.33%9.39%8.14%7.09%6.84%5.87%8.08%7.41%14.41%10.77%8.49%9.61%8.15%
Operating Income Growth %--2.06%72.25%-29.55%-36.28%39.02%2.42%5%14.58%3.32%3.8%-3.75%2.34%-0.22%-4.46%15.88%13.85%2336.94%-103.69%22.49%12.67%6.71%32.7%10.57%38.55%-8.56%13.31%28.17%-14.09%33.74%22.76%
EBITDA6.2B5.75B5.74B3.88B4.94B6.89B5.33B5.23B4.58B3.77B3.65B3.54B3.66B3.62B3.64B3.82B3.38B3.07B650M3.73B3.15B2.93B2.76B2.17B1.92B1.65B1.48B1.36B1.15B1.3B1.02B
EBITDA Margin %14.64%13.71%13.99%9.86%13.5%19.32%14.49%15.47%15.22%14.63%14.89%15.06%15.25%14.67%14.43%14.46%12.02%9.09%1.92%11.63%10.43%9.55%9.24%8.29%11.14%12.16%19.41%15.1%12.91%14.18%12.7%
EBITDA Growth %17.48%0.21%48.13%-21.61%-28.26%29.22%1.87%14.28%21.36%3.43%2.99%-3.14%1.11%-0.6%-4.71%12.95%10.23%372%-82.55%18.44%7.23%6.35%26.92%13.41%16.19%11.49%8.91%18.19%-11.48%26.63%25.61%
D&A (Non-Cash Add-back)1.51B1.47B1.37B1.34B1.34B1.24B1.27B1.26B800M475M456M467M462M495M510M544M555M585M761M719M691M755M717M635M525M645M381M389M393M418M367M
EBIT5.99B5.73B5.47B2.89B6.34B7.5B4.32B2.97B4.3B4.45B2.98B3.08B3.2B3.12B3.18B3.3B2.63B2.55B-225M3.02B2.63B2.2B1.99B1.47B1.12B1.03B1.1B954M752M880M703M
Net Interest Income-671M-665M-621M-545M-506M-556M-593M-528M-562M-360M-301M-301M-282M-257M-212M-221M-269M-281M-295M000000000000
Interest Income0000000000000000000000000000000
Interest Expense671M665M621M545M506M556M593M528M562M360M301M301M282M257M212M221M269M281M295M000000000000
Other Income/Expense824M788M646M-191M2.23B3.29B-337M-1.42B-38M1.01B-270M-286M-259M-260M-165M-193M-232M-217M-257M-320M-178M-113M-391M-413M-111M-306M-123M-207M-443M-229M-271M
Pretax Income5.52B5.07B5.02B2.35B5.84B8.94B3.73B2.55B3.74B3.05B2.92B2.79B2.94B2.86B2.96B3.08B2.37B2.27B-368M2.69B2.28B2.04B1.61B1.13B1.01B699M975M762M312M651M384M
Pretax Margin %13.03%12.08%12.22%5.97%15.94%25.06%10.13%7.53%12.43%11.82%11.93%11.86%12.25%11.61%11.76%11.67%8.41%6.71%-1.09%8.39%7.55%6.65%5.41%4.32%5.86%5.16%12.8%8.47%3.5%7.11%4.76%
Income Tax944M886M842M290M940M1.93B539M300M513M1.03B723M800M868M911M987M997M462M693M913M883M709M661M522M323M312M272M350M279M118M244M150M
Effective Tax Rate %17.1%17.48%16.79%12.36%16.11%21.63%14.46%11.77%13.71%33.91%24.73%28.67%29.55%31.82%33.29%32.34%19.53%30.58%-248.1%32.87%31.15%32.34%32.32%28.56%30.92%38.91%35.9%36.61%37.82%37.48%39.06%
Net Income4.58B4.18B4.17B2.06B4.9B7B3.19B2.25B3.23B2.02B2.2B1.99B2.07B1.95B1.98B2.12B2.05B1.69B-1.26B1.79B1.54B1.4B1.08B866M64M427M608M467M194M407M234M
Net Margin %10.8%9.97%10.17%5.23%13.38%19.64%8.67%6.64%10.73%7.81%8.98%8.46%8.63%7.92%7.84%8.02%7.29%4.99%-3.72%5.59%5.11%4.56%3.63%3.3%0.37%3.15%7.98%5.19%2.18%4.45%2.9%
Net Income Growth %23.31%0.19%103.02%-58.01%-30.11%119.66%41.86%-30.38%60.25%-8.41%10.55%-3.82%5.99%-1.31%-6.61%3.17%21.77%233.6%-170.5%16.08%10.14%29.15%25.17%1253.13%-85.01%-29.77%30.19%140.72%-52.33%73.93%-7.14%
Net Income (Continuing)4.58B4.18B4.17B2.06B4.9B7B3.19B2.25B3.23B2.87B2.2B1.99B2.07B1.95B1.98B2.09B1.9B1.57B-1.28B1.8B1.57B1.4B1.09B758M455M459M625M474M193M407M264M
Discontinued Operations0000000000000000000000000000000
Minority Interest0000000000000000000000013M139M122M00000
EPS (Diluted)32.1129.0828.3413.5331.4743.5419.0313.2218.4911.4712.1910.399.758.357.817.526.825.21-3.775.124.373.852.972.091.842.374.293.351.402.992.08
EPS Growth %26.09%2.61%109.46%-57.01%-27.72%128.8%43.95%-28.5%61.2%-5.91%17.32%6.56%16.77%6.91%3.86%10.26%30.9%238.2%-173.63%17.16%13.51%29.63%42.11%13.59%-22.36%-44.76%28.06%139.29%-53.18%43.75%-11.86%
EPS (Basic)-29.1428.3913.5731.6143.7019.0813.2818.5911.5512.3010.519.918.507.967.656.915.28-3.775.244.463.933.012.111.872.394.313.371.423.052.11
Diluted Shares Outstanding142.5M143.8M147.3M152M155.6M160.9M167.6M170M174.6M175.6M180.5M191.6M212.1M233.9M253.4M281.6M301.1M323.3M334.5M354.3M358.6M363.2M365M408.61M228.82M172.57M141.76M139.61M139.07M136.12M127.23M
Basic Shares Outstanding142.1M143.5M147M151.5M154.9M160.3M167.1M169.3M173.7M174.4M178.9M189.4M208.8M229.6M248.6M276.8M296.9M319.2M334.5M341.7M345.7M356.5M359.7M404.74M224.9M171.13M141.16M138.78M137.1M133.44M125.12M
Dividend Payout Ratio-30.92%28.41%54.28%21.49%14.03%29.88%39.15%25.43%34.19%29.09%30.3%27.21%27.92%27.05%25.64%26.55%31.97%-28.16%26.07%25.64%29.7%35.22%320.31%37%18.75%23.77%56.19%25.06%37.18%

Key Metrics

Growth RegimeStable
ProfitabilityModerate
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Sentinel program cost overruns

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Remains Modestly Positive

As reported in recent financial statements, Northrop Grumman’s revenue growth has stabilized at a 4.4% year-over-year increase in 2026Q1, reflecting the long-cycle nature of its defense backlog and the ongoing transition of major programs like the B-21 Raider into the low-rate initial production phase.

The company’s revenue trajectory appears tethered to federal procurement cycles rather than broader economic conditions, providing a predictable but constrained growth profile. Investors should monitor whether the current pace of expansion can be sustained as the company navigates the regulatory scrutiny surrounding its major strategic programs.

Structural Margin Volatility Remains Evident

Based on the provided income statement data, gross margins have fluctuated significantly, reaching 19.8% in 2026Q1, which highlights the inherent risks of managing complex, long-term defense contracts where cost-plus and fixed-price structures create periodic pressure on profitability during the transition from development to full-scale production.

The variability in gross margins suggests that operational execution on high-stakes programs is the primary driver of profitability, rather than simple pricing power. The dip in margins during earlier periods indicates that unforeseen cost escalations can rapidly erode the bottom line, necessitating careful oversight of contract performance.

Operating Leverage Constrained by Overhead

According to the quarterly income statement, operating margins have hovered around 10% in recent periods, suggesting that the company’s high fixed-cost base for specialized labor and secure facilities limits its ability to significantly scale operating income faster than gross profit during periods of moderate revenue growth.

The persistence of SG&A expenses relative to operating income implies that the company maintains a heavy administrative and R&D burden to support its classified programs. This structure suggests that meaningful margin expansion may be difficult to achieve without significant improvements in operational efficiency or program-level cost control.

Earnings Quality Impacted by Adjustments

As indicated by the historical data, net income has experienced notable volatility, including a significant loss in 2023Q4, which underscores how non-operating items and accounting adjustments, such as the FAS/CAS pension spread, can distort the underlying earnings power of the business in any given quarter.

The divergence between operating income and net income suggests that investors must look past headline EPS to understand the true cash-generating capacity of the firm. The impact of these accounting nuances warrants further investigation to determine if the current earnings recovery is sustainable or merely a result of favorable adjustments.

Execution Risks Challenge Growth Narrative

Based on the reported figures, the Sentinel program’s cost breach represents a material risk to the company's future profitability, as the potential for mandatory restructuring or budget reallocations could undermine the long-term revenue stability that the market currently prices into the stock's valuation multiples.

Short-term performance may mask deeper operational challenges associated with managing massive, multi-decade infrastructure projects under intense regulatory scrutiny. If the company fails to contain costs on these critical programs, the resulting margin compression could lead to a significant re-rating of the stock by institutional investors.

NOC — Frequently Asked Questions

Quick answers to the most common questions about buying NOC stock.

What was Northrop Grumman Corporation's (NOC) revenue in 2025?

For fiscal year 2025, Northrop Grumman Corporation (NOC) reported total revenue of $41.95B. This represents a 419.8% increase compared to $8.07B in 1996.

Is Northrop Grumman Corporation (NOC) profitable?

Northrop Grumman Corporation (NOC) is profitable, generating $4.18B in net income for the fiscal year ending 2025 with a net profit margin of 10.0%.

What is Northrop Grumman Corporation's operating profit margin?

Northrop Grumman Corporation (NOC) reported an operating income of $4.28B, resulting in an operating profit margin of 10.2%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Northrop Grumman Corporation's gross profit and gross margin?

Northrop Grumman Corporation (NOC) generated $8.31B in gross profit for the year, representing a gross profit margin of 19.8%. This demonstrates the company's core pricing power and production efficiency.